Joint Venture

A leading pharmaceutical company headquartered in Asia wished to set up a Joint Venture Company for manufacturing Oncological Active Pharmaceutical Ingredients (API) and Dosage Formulations as part of its strategic expansion initiatives. Garphi identified a potential collaborator who had excellent track record in the manufacture and development of oncological API and different formulations. It was a win-win situation for both the collaborators. In the backdrop of current IPR landscape the joint venture provides significant benefits for both sides to manufacture a mix of newer & older products. Garphi was not only able to bring both sides onto the table quickly but also provide the requisite transaction advisory services – legal, taxation and structuring etc.… Further it is also involved in the execution of the project as both stakeholders appreciate the significant knowledge inputs and expertise that the Garphi team rendered in the initiation of the project.